BBLGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as BBLGW
Bone Biologics Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.41+0.02 (+3.92%)
Close on Oct 19, 2026
- Market cap
- $737.57K
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$2.0695 (−83.45%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $737.57K
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.19
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$2.89M
- EPS, diluted
- -$2.65
- Book value per share
- $2.18
- Diluted shares
- 2M
Fifteen years at a glance
Fiscal years 2010 to 2025 and trailing twelve months, USD
Revenue
–
Operating income
-$3.06M
Net income
-$2.89M
EPS, diluted
–
Free cash flow
–
Reported periodTrailing twelve months